(January 30, 2014) OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin, a small molecular compound, shows potential for treating ovarian cancer.
The research study was funded in part by an Ann Schreiber Mentored Investigator Award to Dr. Wang, who was the lead author of the study.
Click here to read the abstract.
Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at … Continued
In the final installment of BlackDoctor.org’s six-part video ovarian cancer video series in partnership with Ovarian Cancer Research Alliance (OCRA), the discussion turns to the availability of support and resources … Continued
“Hope is stronger than fear. Knowledge is power.” —Janice, Mentor with OCRA’s Woman to Woman Peer Mentor Program This GivingTuesday, YOU Can Help Shape the Future of Ovarian and Gynecologic … Continued
Get email updates about research news, action alerts, and ways to join the fight.
